Business Context and Reporting Period
Pavmed Inc. (PAVM), an emerging growth company incorporated in Delaware, filed this Form 8-K on January 8, 2021. The report details the closing of a previously announced equity offering.
Key Financial Metrics
This filing reports a capital raise event rather than periodic operating results. Specific metrics include:
- Shares Sold: 6,000,000 shares of common stock.
- Price Per Share: $2.24.
- Total Proceeds: Approximately $13.44 million (calculated as 6,000,000 shares x $2.24).
- Placement Agent: Maxim Group LLC acted as the sole placement agent.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions as this is a current report on a specific transaction, not a financial statement.
Material Changes
The primary material change is the increase in the company's share count and cash reserves resulting from the closed offering. The transaction was executed pursuant to the Company's existing shelf registration statement on Form S-3 (Registration No. 333-248709), which was declared effective on September 17, 2020.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the offering terms. The press release announcing the closing is attached as Exhibit 99.1 and incorporated by reference.
Investor Verification Checklist
- Verify the final net proceeds after deducting placement agent fees and offering expenses, which are not detailed in this summary text.
- Review the attached press release (Exhibit 99.1) for the intended use of proceeds.
- Confirm the updated total share count and potential dilution impact on existing shareholders.
- Check for any lock-up agreements or restrictions on the newly issued shares.